Neuroone Medical Technologies is trading 7.8% up in pre-market at $1.52, amid a broader pre-market recovery across U.S. equities.
- S&P 500, Nasdaq Composite, and Dow Jones futures are each higher by more than 0.5% on September 17, 2026.
- No fresh company-specific announcement was identified.
- Recent coverage focuses on its September 9–10 conference presentation and earlier fiscal-third-quarter developments; the move appears primarily global rather than company-driven.